Evaluating the Safety and Efficacy of Duloxetine in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis
NCT06860984
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Biliary Disease
Interventions
DRUG:
Duloxetine
OTHER:
Placebo capsule
Sponsor
Tanta University